$4.74
In chiusura: Oct 10 EDT
$4.91
0.173.70%
Pre-mercato: 7:14 AM EDT
Comments
Loading...
Stime degli utili, EPS e fatturato
Sonnet BioTherapeutics segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
dic 16
Stima EPS
$-0.490
Stima dei ricavi trimestrali
–
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
$1.00M
Analizza lo storico degli utili di Sonnet BioTherapeutics utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
SONN | Sonnet BioTherapeutics | -$3.67 | -$0.49 | — | — | $0.00 | — | — | — | 12/16/2025 | |
SONN | Sonnet BioTherapeutics | -$5.60 | -$0.49 | -$0.95 | -93.88% | $0.00 | — | $0.00 | — | 08/13/2025 | |
SONN | Sonnet BioTherapeutics | $0.56 | -$0.79 | -$0.89 | -12.66% | $0.00 | — | $0.00 | — | 05/13/2025 | |
SONN | Sonnet BioTherapeutics | -$2.46 | -$1.39 | -$1.56 | -12.23% | $18.63K | — | $0.00 | — | 02/13/2025 | |
SONN | Sonnet BioTherapeutics | -$6.24 | -$5.04 | -$3.67 | 27.18% | $37.26K | $30.00K | $0.00 | -100.00% | 12/17/2024 | |
SONN | Sonnet BioTherapeutics | -$23.60 | -$6.08 | -$5.60 | 7.89% | $36.85K | $30.00K | $0.00 | -100.00% | 08/14/2024 | |
SONN | Sonnet BioTherapeutics | -$60.40 | $1.04 | $0.56 | -46.15% | $36.45K | $10.00K | $0.00 | -100.00% | 05/14/2024 | |
SONN | Sonnet BioTherapeutics | -$140.80 | -$7.20 | -$2.48 | 65.56% | $37.26K | $20.00K | $18.63K | -6.87% | 02/14/2024 | |
SONN | Sonnet BioTherapeutics | -$292.16 | -$7.20 | -$6.24 | 13.33% | $62.75K | $20.00K | $37.26K | 86.27% | 12/14/2023 | |
SONN | Sonnet BioTherapeutics | -$320.32 | -$54.56 | -$22.88 | 58.06% | $62.07K | — | $36.85K | — | 08/14/2023 | |
SONN | Sonnet BioTherapeutics | -$336.16 | — | -$59.84 | — | $95.32K | — | $36.45K | — | 05/10/2023 | |
SONN | Sonnet BioTherapeutics | -$246.40 | — | -$140.80 | — | $129.80K | — | $37.26K | — | 02/13/2023 | |
SONN | Sonnet BioTherapeutics | -$221.76 | — | -$292.16 | — | $0.00 | — | $62.75K | — | 12/15/2022 | |
SONN | Sonnet BioTherapeutics | -$665.28 | — | -$320.32 | — | $0.00 | — | $62.07K | — | 08/15/2022 | |
SONN | Sonnet BioTherapeutics | -$788.48 | — | -$344.96 | — | $0.00 | — | $95.32K | — | 05/10/2022 | |
SONN | Sonnet BioTherapeutics | -$837.76 | — | -$246.40 | — | $0.00 | — | $129.80K | — | 02/08/2022 | |
SONN | Sonnet BioTherapeutics | -$11.65K | — | -$221.76 | — | $0.00 | — | $0.00 | — | 12/17/2021 | |
SONN | Sonnet BioTherapeutics | -$1.08K | — | -$665.28 | — | $0.00 | — | $0.00 | — | 08/16/2021 | |
SONN | Sonnet BioTherapeutics | -$123.20 | — | -$788.48 | — | $0.00 | — | $0.00 | — | 05/17/2021 | |
SONN | Sonnet BioTherapeutics | -$1.08K | — | -$837.76 | — | — | — | $0.00 | — | 02/16/2021 | |
SONN | Sonnet BioTherapeutics | — | — | -$11.65K | — | — | — | $0.00 | — | 12/17/2020 |
Sonnet BioTherapeutics (SONN) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | 2025-08-13 | $-0.95 | $-0.49 | -93.9 % |
| Q2 | 2025-05-13 | $-0.89 | $-0.79 | -12.7 % |
| Q1 | 2025-02-13 | $-1.56 | $-1.39 | -12.2 % |
| Q4 | 2024-12-17 | $-3.67 | $-5.04 | 27.2 % |
Sonnet BioTherapeutics (SONN) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q4 | 2024-12-17 | $0 | $30.00K | -100.0 % |
| Q3 | 2024-08-14 | $0 | $30.00K | -100.0 % |
| Q2 | 2024-05-14 | $0 | $10.00K | -100.0 % |
| Q1 | 2024-02-14 | $18.63K | $20.00K | -6.87 % |
FAQ
Quando Sonnet BioTherapeutics (NASDAQ:SONN) riporterà gli utili?
Si prevede che Sonnet BioTherapeutics (SONN) fornisca risultati il dicembre 16, 2025. Gli ultimi risultati sono stati pubblicati il agosto 13, 2025 per il Q3.
Quali sono stati gli ultimi utili per azione (EPS) di Sonnet BioTherapeutics (NASDAQ:SONN)?
L'EPS effettivo era $-0.95, che mancato la stima di $-0.49.
Quali sono state le entrate di Sonnet BioTherapeutics (NASDAQ:SONN)?
Le entrate effettive sono state $0K, che centrato la stima di $0K.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.